EC50 of Epidural Ropivacaine Combined With Dexmedetomidine for Labor Analgesia

BACKGROUND:It has been reported that the optimal concentration of epidural dexmedetomidine for labor analgesia is 0.5 μg/mL when combined with 0.1% ropivacaine. This study investigated the median effective concentration (EC50) of epidural ropivacaine for labor analgesia when combined with 0.5 μg/mL...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Clinical journal of pain 2018-10, Vol.34 (10), p.950-953
Hauptverfasser: Zhang, Wp, Li, Cuiling
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 953
container_issue 10
container_start_page 950
container_title The Clinical journal of pain
container_volume 34
creator Zhang, Wp
Li, Cuiling
description BACKGROUND:It has been reported that the optimal concentration of epidural dexmedetomidine for labor analgesia is 0.5 μg/mL when combined with 0.1% ropivacaine. This study investigated the median effective concentration (EC50) of epidural ropivacaine for labor analgesia when combined with 0.5 μg/mL dexmedetomidine. MATERIALS AND METHODS:Sixty full-term primiparas were enrolled and divided into 2 groups in this prospective study. Group D received 10 mL solution (ropivacaine+0.5 μg/mL dexmedetomidine) in the induction of epidural anesthesia, and group C (control group) received 10 mL of ropivacaine alone. The dose of epidural ropivacaine was decided by using the up-and-down sequential allocation method with an initial concentration of 0.1%×0.01% gradient. Effective analgesia was defined as the visual analogue scale for pain as ≤3 within 30 minutes after epidural injection when cervical dilation is about 2 cm. The EC50 of ropivacaine was calculated by the Massey formula. Hemodynamic parameters, the stages of labor, and fetal heart rate were recorded. Neonatal Apgar scores and umbilical artery pH were also recorded. The side effects, if any, were noted. RESULTS:The EC50 of ropivacaine was 0.062% (95% confidence interval [CI], 0.058%-0.066%) in the group D, and 0.083% (95% CI, 0.077%-0.089%) in the group C, there was a significant difference between the groups (P
doi_str_mv 10.1097/AJP.0000000000000613
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2019811132</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2019811132</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4023-2181ac97176b13a089792d67aba3e20c56a44b1973edb206150da5f49d5b431b3</originalsourceid><addsrcrecordid>eNp9UMtOwzAQtBCIlscfIJQjlxQ_4_hYlfJSBQiBOFp24lBDUgc7ofD3uGpBiAN72DnszKxmADhCcISg4Kfj67sR_D0ZIltgiBjJUkah2AZDyKlIc0j5AOyF8AIhYjiHu2CABROMYTEEN9MJg4mrkmlry96rOrl3rX1XhbILk0xcoyOWyZPt5smZ-WhMaTrX2HJ1rZxPZkrHPV6o-tkEqw7ATqXqYA43uA8ez6cPk8t0dntxNRnP0oJCTFKMcqQKwRHPNCIK5oILXGZcaUUMhgXLFKUaCU5MqXFMxmCpWEVFyTQlSJN9cLL2bb17603oZGNDYepaLYzrg8QQiRwhRHCk0jW18C4EbyrZetso_ykRlKsmZWxS_m0yyo43H3odU_-IvquLhHxNWLq6Mz681v3SeDk3qu7m_3t_AVbpfTw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2019811132</pqid></control><display><type>article</type><title>EC50 of Epidural Ropivacaine Combined With Dexmedetomidine for Labor Analgesia</title><source>Journals@Ovid Complete</source><creator>Zhang, Wp ; Li, Cuiling</creator><creatorcontrib>Zhang, Wp ; Li, Cuiling</creatorcontrib><description>BACKGROUND:It has been reported that the optimal concentration of epidural dexmedetomidine for labor analgesia is 0.5 μg/mL when combined with 0.1% ropivacaine. This study investigated the median effective concentration (EC50) of epidural ropivacaine for labor analgesia when combined with 0.5 μg/mL dexmedetomidine. MATERIALS AND METHODS:Sixty full-term primiparas were enrolled and divided into 2 groups in this prospective study. Group D received 10 mL solution (ropivacaine+0.5 μg/mL dexmedetomidine) in the induction of epidural anesthesia, and group C (control group) received 10 mL of ropivacaine alone. The dose of epidural ropivacaine was decided by using the up-and-down sequential allocation method with an initial concentration of 0.1%×0.01% gradient. Effective analgesia was defined as the visual analogue scale for pain as ≤3 within 30 minutes after epidural injection when cervical dilation is about 2 cm. The EC50 of ropivacaine was calculated by the Massey formula. Hemodynamic parameters, the stages of labor, and fetal heart rate were recorded. Neonatal Apgar scores and umbilical artery pH were also recorded. The side effects, if any, were noted. RESULTS:The EC50 of ropivacaine was 0.062% (95% confidence interval [CI], 0.058%-0.066%) in the group D, and 0.083% (95% CI, 0.077%-0.089%) in the group C, there was a significant difference between the groups (P&lt;0.05). CONCLUSIONS:The EC50 of epidural ropivacaine for labor analgesia was 0.083% (95% CI, 0.077%-0.089%) and decreased to 0.062% (95% CI, 0.058%-0.066%) when combined with 0.5 μg/mL dexmedetomidine (http://www.chictr.org.cn, registration numberChiCTR-OPC-16008548).</description><identifier>ISSN: 0749-8047</identifier><identifier>EISSN: 1536-5409</identifier><identifier>DOI: 10.1097/AJP.0000000000000613</identifier><identifier>PMID: 29595529</identifier><language>eng</language><publisher>United States: Copyright Wolters Kluwer Health, Inc. All rights reserved</publisher><ispartof>The Clinical journal of pain, 2018-10, Vol.34 (10), p.950-953</ispartof><rights>Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4023-2181ac97176b13a089792d67aba3e20c56a44b1973edb206150da5f49d5b431b3</citedby><cites>FETCH-LOGICAL-c4023-2181ac97176b13a089792d67aba3e20c56a44b1973edb206150da5f49d5b431b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29595529$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhang, Wp</creatorcontrib><creatorcontrib>Li, Cuiling</creatorcontrib><title>EC50 of Epidural Ropivacaine Combined With Dexmedetomidine for Labor Analgesia</title><title>The Clinical journal of pain</title><addtitle>Clin J Pain</addtitle><description>BACKGROUND:It has been reported that the optimal concentration of epidural dexmedetomidine for labor analgesia is 0.5 μg/mL when combined with 0.1% ropivacaine. This study investigated the median effective concentration (EC50) of epidural ropivacaine for labor analgesia when combined with 0.5 μg/mL dexmedetomidine. MATERIALS AND METHODS:Sixty full-term primiparas were enrolled and divided into 2 groups in this prospective study. Group D received 10 mL solution (ropivacaine+0.5 μg/mL dexmedetomidine) in the induction of epidural anesthesia, and group C (control group) received 10 mL of ropivacaine alone. The dose of epidural ropivacaine was decided by using the up-and-down sequential allocation method with an initial concentration of 0.1%×0.01% gradient. Effective analgesia was defined as the visual analogue scale for pain as ≤3 within 30 minutes after epidural injection when cervical dilation is about 2 cm. The EC50 of ropivacaine was calculated by the Massey formula. Hemodynamic parameters, the stages of labor, and fetal heart rate were recorded. Neonatal Apgar scores and umbilical artery pH were also recorded. The side effects, if any, were noted. RESULTS:The EC50 of ropivacaine was 0.062% (95% confidence interval [CI], 0.058%-0.066%) in the group D, and 0.083% (95% CI, 0.077%-0.089%) in the group C, there was a significant difference between the groups (P&lt;0.05). CONCLUSIONS:The EC50 of epidural ropivacaine for labor analgesia was 0.083% (95% CI, 0.077%-0.089%) and decreased to 0.062% (95% CI, 0.058%-0.066%) when combined with 0.5 μg/mL dexmedetomidine (http://www.chictr.org.cn, registration numberChiCTR-OPC-16008548).</description><issn>0749-8047</issn><issn>1536-5409</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9UMtOwzAQtBCIlscfIJQjlxQ_4_hYlfJSBQiBOFp24lBDUgc7ofD3uGpBiAN72DnszKxmADhCcISg4Kfj67sR_D0ZIltgiBjJUkah2AZDyKlIc0j5AOyF8AIhYjiHu2CABROMYTEEN9MJg4mrkmlry96rOrl3rX1XhbILk0xcoyOWyZPt5smZ-WhMaTrX2HJ1rZxPZkrHPV6o-tkEqw7ATqXqYA43uA8ez6cPk8t0dntxNRnP0oJCTFKMcqQKwRHPNCIK5oILXGZcaUUMhgXLFKUaCU5MqXFMxmCpWEVFyTQlSJN9cLL2bb17603oZGNDYepaLYzrg8QQiRwhRHCk0jW18C4EbyrZetso_ykRlKsmZWxS_m0yyo43H3odU_-IvquLhHxNWLq6Mz681v3SeDk3qu7m_3t_AVbpfTw</recordid><startdate>201810</startdate><enddate>201810</enddate><creator>Zhang, Wp</creator><creator>Li, Cuiling</creator><general>Copyright Wolters Kluwer Health, Inc. All rights reserved</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201810</creationdate><title>EC50 of Epidural Ropivacaine Combined With Dexmedetomidine for Labor Analgesia</title><author>Zhang, Wp ; Li, Cuiling</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4023-2181ac97176b13a089792d67aba3e20c56a44b1973edb206150da5f49d5b431b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Wp</creatorcontrib><creatorcontrib>Li, Cuiling</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Clinical journal of pain</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Wp</au><au>Li, Cuiling</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>EC50 of Epidural Ropivacaine Combined With Dexmedetomidine for Labor Analgesia</atitle><jtitle>The Clinical journal of pain</jtitle><addtitle>Clin J Pain</addtitle><date>2018-10</date><risdate>2018</risdate><volume>34</volume><issue>10</issue><spage>950</spage><epage>953</epage><pages>950-953</pages><issn>0749-8047</issn><eissn>1536-5409</eissn><abstract>BACKGROUND:It has been reported that the optimal concentration of epidural dexmedetomidine for labor analgesia is 0.5 μg/mL when combined with 0.1% ropivacaine. This study investigated the median effective concentration (EC50) of epidural ropivacaine for labor analgesia when combined with 0.5 μg/mL dexmedetomidine. MATERIALS AND METHODS:Sixty full-term primiparas were enrolled and divided into 2 groups in this prospective study. Group D received 10 mL solution (ropivacaine+0.5 μg/mL dexmedetomidine) in the induction of epidural anesthesia, and group C (control group) received 10 mL of ropivacaine alone. The dose of epidural ropivacaine was decided by using the up-and-down sequential allocation method with an initial concentration of 0.1%×0.01% gradient. Effective analgesia was defined as the visual analogue scale for pain as ≤3 within 30 minutes after epidural injection when cervical dilation is about 2 cm. The EC50 of ropivacaine was calculated by the Massey formula. Hemodynamic parameters, the stages of labor, and fetal heart rate were recorded. Neonatal Apgar scores and umbilical artery pH were also recorded. The side effects, if any, were noted. RESULTS:The EC50 of ropivacaine was 0.062% (95% confidence interval [CI], 0.058%-0.066%) in the group D, and 0.083% (95% CI, 0.077%-0.089%) in the group C, there was a significant difference between the groups (P&lt;0.05). CONCLUSIONS:The EC50 of epidural ropivacaine for labor analgesia was 0.083% (95% CI, 0.077%-0.089%) and decreased to 0.062% (95% CI, 0.058%-0.066%) when combined with 0.5 μg/mL dexmedetomidine (http://www.chictr.org.cn, registration numberChiCTR-OPC-16008548).</abstract><cop>United States</cop><pub>Copyright Wolters Kluwer Health, Inc. All rights reserved</pub><pmid>29595529</pmid><doi>10.1097/AJP.0000000000000613</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0749-8047
ispartof The Clinical journal of pain, 2018-10, Vol.34 (10), p.950-953
issn 0749-8047
1536-5409
language eng
recordid cdi_proquest_miscellaneous_2019811132
source Journals@Ovid Complete
title EC50 of Epidural Ropivacaine Combined With Dexmedetomidine for Labor Analgesia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T10%3A30%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=EC50%20of%20Epidural%20Ropivacaine%20Combined%20With%20Dexmedetomidine%20for%20Labor%20Analgesia&rft.jtitle=The%20Clinical%20journal%20of%20pain&rft.au=Zhang,%20Wp&rft.date=2018-10&rft.volume=34&rft.issue=10&rft.spage=950&rft.epage=953&rft.pages=950-953&rft.issn=0749-8047&rft.eissn=1536-5409&rft_id=info:doi/10.1097/AJP.0000000000000613&rft_dat=%3Cproquest_cross%3E2019811132%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2019811132&rft_id=info:pmid/29595529&rfr_iscdi=true